Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116815423 | 11681542 | 3 | F | 2007 | 20160914 | 20151029 | 20160929 | EXP | US-AUROBINDO-AUR-APU-2015-06582 | AUROBINDO | 0.00 | M | Y | 86.00000 | KG | 20160929 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116815423 | 11681542 | 1 | PS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 20 MG, UNK | U | 77031 | 20 | MG | |||||||
| 116815423 | 11681542 | 2 | SS | Meloxicam 15mg | MELOXICAM | 1 | Unknown | 15 MG, UNK | U | 0 | 15 | MG | |||||||
| 116815423 | 11681542 | 3 | SS | Meloxicam 15mg | MELOXICAM | 1 | U | 0 | |||||||||||
| 116815423 | 11681542 | 4 | SS | Oxycodone | OXYCODONE | 1 | Unknown | 10 MG, UNK | U | 0 | 10 | MG | |||||||
| 116815423 | 11681542 | 5 | SS | CYCLOBENZAPRIN HCL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | Unknown | 10 MG, UNK | U | 0 | 10 | MG | |||||||
| 116815423 | 11681542 | 6 | SS | CYCLOBENZAPRIN HCL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 116815423 | 11681542 | 7 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 300 MG, FOUR TIMES/DAY | Y | U | 0 | 300 | MG | CAPSULE | QID | ||||
| 116815423 | 11681542 | 8 | SS | GABAPENTIN. | GABAPENTIN | 1 | Y | U | 0 | CAPSULE | |||||||||
| 116815423 | 11681542 | 9 | SS | GABAPENTIN. | GABAPENTIN | 1 | Y | U | 0 | CAPSULE | |||||||||
| 116815423 | 11681542 | 10 | SS | GABAPENTIN. | GABAPENTIN | 1 | Y | U | 0 | CAPSULE | |||||||||
| 116815423 | 11681542 | 11 | SS | TIZADINE | TIZANIDINE HYDROCHLORIDE | 1 | Unknown | U | U | 0 | |||||||||
| 116815423 | 11681542 | 12 | SS | VALIUM | DIAZEPAM | 1 | Unknown | U | U | 0 | |||||||||
| 116815423 | 11681542 | 13 | C | FLECTOR /00372302/ | DICLOFENAC SODIUM | 1 | Unknown | U | 0 | ||||||||||
| 116815423 | 11681542 | 14 | C | LIALDA | MESALAMINE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116815423 | 11681542 | 1 | Depression |
| 116815423 | 11681542 | 2 | Inflammation |
| 116815423 | 11681542 | 3 | Back disorder |
| 116815423 | 11681542 | 4 | Pain management |
| 116815423 | 11681542 | 5 | Back pain |
| 116815423 | 11681542 | 6 | Sciatica |
| 116815423 | 11681542 | 7 | Radiculopathy |
| 116815423 | 11681542 | 8 | Pain |
| 116815423 | 11681542 | 9 | Abdominal discomfort |
| 116815423 | 11681542 | 10 | Paraesthesia |
| 116815423 | 11681542 | 11 | Product used for unknown indication |
| 116815423 | 11681542 | 12 | Product used for unknown indication |
| 116815423 | 11681542 | 13 | Muscle spasms |
| 116815423 | 11681542 | 14 | Colitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116815423 | 11681542 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116815423 | 11681542 | Drug ineffective | |
| 116815423 | 11681542 | Feeling abnormal | |
| 116815423 | 11681542 | Intervertebral disc protrusion | |
| 116815423 | 11681542 | Post laminectomy syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116815423 | 11681542 | 1 | 2008 | 0 | ||
| 116815423 | 11681542 | 2 | 2012 | 0 | ||
| 116815423 | 11681542 | 4 | 2012 | 0 | ||
| 116815423 | 11681542 | 5 | 2012 | 0 | ||
| 116815423 | 11681542 | 7 | 2006 | 201506 | 0 | |
| 116815423 | 11681542 | 14 | 2007 | 0 |